Study A - MK0767 Monotherapy Study

The purpose of this study is to test if MK0767 lowers blood glucose after 20 weeks compared to placebo.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Inclusion Criteria:

• Patients with Type 2 Diabetes
• Non-pregnant females and patients who agree not to become pregnant during the study

Exclusion Criteria:

• Patients with Type 1 Diabetes
• Patients who have been treated with insulin or other antihyperglycemic agents
• Patients with viral hepatitis, active liver or gallbladder disease, history of pancreatitis, heart disease, congestive heart failure, inadequately controlled hypertension, HIV positive, history hematologic disorders or neoplastic disease